Elevance Health, Inc. (ELV)

Data as of Oct 6, 2026, from SEC Form 4 filings.

S&P 500Net insider buying (90d)Watch ELV

See up to 3 months of ELV. The 7-day demo opens the 1M and 3M ranges and puts ELV on your watchlist.

Latest ELV insider trades

Ramiro G. Peru - Director
Open-market purchase$366K
Jul 17, 2026
Gail Boudreaux - Officer
Open-market purchase$249K
Jul 17, 2026

About Elevance Health, Inc. (ELV)

Elevance Health, Inc. is an SEC registrant, filing under CIK 0001156039, classified as hospital and medical service plans. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for ELV on EDGAR

ELV Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market purchase	3	3,725	$1.37M
Grant or award	1	2,627
Tax withholding / forfeiture	4	4,654

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

ELV insider transactions (Form 4)

53 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Oct 2, 2026	Mark Kaye - Officer	Tax withholding / forfeiture	Common Stock	4,161^{footnote F1}	$386.43	$1.61M
Oct 2, 2026	Mark Kaye - Officer	Grant or award	Common Stock	2,627^{footnote F2}	$0.00	-
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.
Sep 2, 2026	Erin M. Wessling - Officer	Tax withholding / forfeiture	Common Stock	94^{footnote F1}	$405.84	$38K
Sep 3, 2026	Erin M. Wessling - Officer	Tax withholding / forfeiture	Common Stock	255^{footnote F1}	$414.78	$106K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Sep 2, 2026	Ryan R. Craig - Officer	Tax withholding / forfeiture	Common Stock	144^{footnote F1}	$405.84	$58K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Jul 17, 2026	Ramiro G. Peru - Director	Open-market purchase	Common Stock	1,000	$366.05	$366K
Jul 17, 2026	Gail Boudreaux - Officer	Open-market purchase	Common Stock	680	$366.41^{footnote F1}	$249K
Jul 17, 2026	Gail Boudreaux - Officer	Open-market purchase	Common Stock	2,045	$368.25^{footnote F2}	$753K
Footnote F1 (price): This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the… Full note on SEC EDGAR Footnote F2 (price): This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the… Full note on SEC EDGAR
Jun 12, 2026	Ronald W. Penczek - Officer	Open-market sale	Common Stock	369	$403.16^{footnote F1}	$149K
Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer… Full note on SEC EDGAR
Jun 11, 2026	Robert L. Dixon Jr. - Director	Open-market sale	Common Stock	151	$401.77	$61K
May 19, 2026	Ronald W. Penczek - Officer	Option exercise	Common Stock	877	$311.48	$273K
May 19, 2026	Ronald W. Penczek - Officer	Option exercise	Common Stock	654	$271.27	$177K
May 19, 2026	Ronald W. Penczek - Officer	Open-market sale	Common Stock	1,531	$403.13^{footnote F2}	$617K
May 19, 2026	Ronald W. Penczek - Officer	Option exercise	Employee Stock Option (Right to Buy)	654	$0.00	-
May 19, 2026	Ronald W. Penczek - Officer	Option exercise	Employee Stock Option (Right to Buy)	877	$0.00	-
Footnote F2 (price): This transaction was executed in multiple trades, each at the same price of $403.13.
May 13, 2026	Deanna D. Strable-Soethout - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Amy W. Schulman - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Ryan M. Schneider - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Ramiro G. Peru - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Antonio F. Neri - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Bahija Jallal - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Lewis Hay III - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Robert L. Dixon Jr. - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Susan D. Devore - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
May 13, 2026	Steven H. Collis - Director	Grant or award	Common Stock	563^{footnote F1,F2}	$0.00	-
Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR
Mar 12, 2026	Amy W. Schulman - Director	Open-market sale	Common Stock	26	$287.50	$7K
Mar 6, 2026	Charles Morgan Kendrick Jr. - Officer	Open-market sale	Common Stock	3,196	$284.92^{footnote F1}	$911K
Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer… Full note on SEC EDGAR
Mar 5, 2026	Steven H. Collis - Director	Open-market purchase	Common Stock	3,000	$289.84	$870K
Mar 2, 2026	Ronald W. Penczek - Officer	Grant or award	Common Stock	426^{footnote F3}	$0.00	-
Mar 2, 2026	Ronald W. Penczek - Officer	Grant or award	Common Stock	1,701^{footnote F4}	$0.00	-
Mar 2, 2026	Ronald W. Penczek - Officer	Grant or award	Common Stock	266^{footnote F5}	$0.00	-
Mar 3, 2026	Ronald W. Penczek - Officer	Tax withholding / forfeiture	Common Stock	37^{footnote F1}	$284.03	$11K
Mar 2, 2026	Ronald W. Penczek - Officer	Grant or award	Employee Stock Option (Right to Buy)	1,677	$0.00	-
Mar 2, 2026	Ronald W. Penczek - Officer	Tax withholding / forfeiture	Common Stock	131^{footnote F1}	$294.07	$39K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Footnote F4 (shares): Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028. Footnote F5 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Mar 2, 2026	Erin M. Wessling - Officer	Grant or award	Common Stock	2,976^{footnote F1}	$0.00	-
Mar 3, 2026	Erin M. Wessling - Officer	Tax withholding / forfeiture	Common Stock	417^{footnote F2}	$284.03	$118K
Mar 2, 2026	Erin M. Wessling - Officer	Grant or award	Employee Stock Option (Right to Buy)	11,754	$0.00	-
Footnote F1 (shares): Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Footnote F2 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Mar 3, 2026	Ryan R. Craig - Officer	Tax withholding / forfeiture	Common Stock	309^{footnote F1}	$284.03	$88K
Mar 2, 2026	Ryan R. Craig - Officer	Grant or award	Employee Stock Option (Right to Buy)	11,754	$0.00	-
Mar 2, 2026	Ryan R. Craig - Officer	Tax withholding / forfeiture	Common Stock	25^{footnote F1}	$294.07	$7K
Mar 2, 2026	Ryan R. Craig - Officer	Grant or award	Common Stock	2,976^{footnote F2}	$0.00	-
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
Mar 2, 2026	Felicia F. Norwood - Officer	Grant or award	Common Stock	5,951^{footnote F2}	$0.00	-
Mar 2, 2026	Felicia F. Norwood - Officer	Grant or award	Common Stock	2,865^{footnote F3}	$0.00	-
Mar 3, 2026	Felicia F. Norwood - Officer	Tax withholding / forfeiture	Common Stock	496^{footnote F1}	$284.03	$141K
Mar 2, 2026	Felicia F. Norwood - Officer	Grant or award	Employee Stock Option (Right to Buy)	23,512	$0.00	-
Mar 2, 2026	Felicia F. Norwood - Officer	Tax withholding / forfeiture	Common Stock	1,421^{footnote F1}	$294.07	$418K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029. Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Mar 2, 2026	Ratnakar Lavu - Officer	Grant or award	Employee Stock Option (Right to Buy)	20,152	$0.00	-
Mar 2, 2026	Ratnakar Lavu - Officer	Tax withholding / forfeiture	Common Stock	315^{footnote F1}	$294.07	$93K
Mar 2, 2026	Ratnakar Lavu - Officer	Grant or award	Common Stock	5,101^{footnote F2}	$0.00	-
Mar 2, 2026	Ratnakar Lavu - Officer	Grant or award	Common Stock	6,802^{footnote F3}	$0.00	-
Mar 3, 2026	Ratnakar Lavu - Officer	Tax withholding / forfeiture	Common Stock	222^{footnote F1}	$284.03	$63K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,700 shares each on 3/2/2027 and 3/2/2028, and 1,701 on 3/2/2029. Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 3,401 shares each on 3/2/2027 and 3/2/2028.
Mar 3, 2026	Charles Morgan Kendrick Jr. - Officer	Tax withholding / forfeiture	Common Stock	467^{footnote F1}	$284.03	$133K
Mar 2, 2026	Charles Morgan Kendrick Jr. - Officer	Grant or award	Employee Stock Option (Right to Buy)	15,870	$0.00	-
Mar 2, 2026	Charles Morgan Kendrick Jr. - Officer	Tax withholding / forfeiture	Common Stock	1,211^{footnote F1}	$294.07	$356K
Mar 2, 2026	Charles Morgan Kendrick Jr. - Officer	Grant or award	Common Stock	4,017^{footnote F2}	$0.00	-
Mar 2, 2026	Charles Morgan Kendrick Jr. - Officer	Grant or award	Common Stock	2,532^{footnote F3}	$0.00	-
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029. Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Mar 2, 2026	Peter D. Haytaian - Officer	Tax withholding / forfeiture	Common Stock	1,201^{footnote F1}	$294.07	$353K
Mar 2, 2026	Peter D. Haytaian - Officer	Grant or award	Common Stock	2,865^{footnote F2}	$0.00	-
Mar 3, 2026	Peter D. Haytaian - Officer	Tax withholding / forfeiture	Common Stock	446^{footnote F1}	$284.03	$127K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Mar 2, 2026	Mark Kaye - Officer	Grant or award	Employee Stock Option (Right to Buy)	25,188	$0.00	-
Mar 2, 2026	Mark Kaye - Officer	Tax withholding / forfeiture	Common Stock	271^{footnote F1}	$294.07	$80K
Mar 2, 2026	Mark Kaye - Officer	Grant or award	Common Stock	6,377^{footnote F2}	$0.00	-
Mar 2, 2026	Mark Kaye - Officer	Grant or award	Common Stock	10,202^{footnote F3}	$0.00	-
Mar 3, 2026	Mark Kaye - Officer	Tax withholding / forfeiture	Common Stock	353^{footnote F1}	$284.03	$100K
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029. Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.
Mar 2, 2026	Gail Boudreaux - Officer	Grant or award	Common Stock	10,527^{footnote F3}	$0.00	-
Mar 3, 2026	Gail Boudreaux - Officer	Tax withholding / forfeiture	Common Stock	1,736^{footnote F1}	$284.03	$493K
Mar 2, 2026	Gail Boudreaux - Officer	Grant or award	Employee Stock Option (Right to Buy)	63,818	$0.00	-
Mar 2, 2026	Gail Boudreaux - Officer	Tax withholding / forfeiture	Common Stock	6,713^{footnote F1}	$294.07	$1.97M
Mar 2, 2026	Gail Boudreaux - Officer	Grant or award	Common Stock	16,153^{footnote F2}	$0.00	-
Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029. Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Recent ELV Form 8-K filings

Read ELV company news

Sep 10, 2026Item 7.01

Read the filing on SEC EDGAR

Jul 15, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jun 10, 2026Item 7.01

Read the filing on SEC EDGAR

May 13, 2026Item 5.07

Read the filing on SEC EDGAR

Recent ELV Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Jul 7, 2026	-	-	-	-	View on EDGAR
Jun 12, 2026	-	-	-	-

ELV insider trading FAQ

What is the latest insider trade for ELV?

Elevance Health, Inc. (ELV) had 5 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for ELV runs to 53 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying ELV stock?

3 insider purchases of ELV were filed in the last 90 days, totaling $1.37M.

How many insiders are selling ELV stock?

No insider sales of ELV were filed in the last 90 days. 7 sales are on record for this company.

Where can I see ELV SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects ELV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Oct 6, 2026 - Mark Kaye view on EDGAR
Sep 4, 2026 - Erin M. Wessling view on EDGAR
Sep 4, 2026 - Ryan R. Craig view on EDGAR
Jul 17, 2026 - Ramiro G. Peru view on EDGAR
Jul 17, 2026 - Gail Boudreaux view on EDGAR
Jun 15, 2026 - Ronald W. Penczek view on EDGAR
Jun 12, 2026 - Robert L. Dixon Jr. view on EDGAR
May 20, 2026 - Ronald W. Penczek view on EDGAR
May 15, 2026 - Deanna D. Strable-Soethout view on EDGAR

Related companies with recent insider activity

Learn more

How to read insider buying signals: What an open-market purchase by an insider can and cannot tell you.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where ELV's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow ELV with a 7-day demo

ELV on your watchlist
Every ELV Form 4 filing on record
Up to 3 months of ELV price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market purchase

3,725

$1.37M

Grant or award

2,627

Tax withholding / forfeiture

4,654

Date

Insider

Transaction

Security

Price

Value

Oct 2, 2026

Mark Kaye - Officer

Tax withholding / forfeiture

Common Stock

4,161^{footnote F1}

$386.43

$1.61M

Oct 2, 2026

Mark Kaye - Officer

Grant or award

Common Stock

2,627^{footnote F2}

$0.00

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.

Sep 2, 2026

Erin M. Wessling - Officer

Tax withholding / forfeiture

Common Stock

94^{footnote F1}

$405.84

$38K

Sep 3, 2026

Erin M. Wessling - Officer

Tax withholding / forfeiture

Common Stock

255^{footnote F1}

$414.78

$106K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Sep 2, 2026

Ryan R. Craig - Officer

Tax withholding / forfeiture

Common Stock

144^{footnote F1}

$405.84

$58K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Jul 17, 2026

Ramiro G. Peru - Director

Open-market purchase

Common Stock

1,000

$366.05

$366K

Jul 17, 2026

Gail Boudreaux - Officer

Open-market purchase

Common Stock

680

$366.41^{footnote F1}

$249K

Jul 17, 2026

Gail Boudreaux - Officer

Open-market purchase

Common Stock

2,045

$368.25^{footnote F2}

$753K

Footnote F1 (price): This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the… Full note on SEC EDGAR
Footnote F2 (price): This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the… Full note on SEC EDGAR

Jun 12, 2026

Ronald W. Penczek - Officer

Open-market sale

Common Stock

369

$403.16^{footnote F1}

$149K

Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer… Full note on SEC EDGAR

Jun 11, 2026

Robert L. Dixon Jr. - Director

Open-market sale

Common Stock

151

$401.77

$61K

May 19, 2026

Ronald W. Penczek - Officer

Option exercise

Common Stock

877

$311.48

$273K

May 19, 2026

Ronald W. Penczek - Officer

Option exercise

Common Stock

654

$271.27

$177K

May 19, 2026

Ronald W. Penczek - Officer

Open-market sale

Common Stock

1,531

$403.13^{footnote F2}

$617K

May 19, 2026

Ronald W. Penczek - Officer

Option exercise

Employee Stock Option (Right to Buy)

654

$0.00

May 19, 2026

Ronald W. Penczek - Officer

Option exercise

Employee Stock Option (Right to Buy)

877

$0.00

Footnote F2 (price): This transaction was executed in multiple trades, each at the same price of $403.13.

May 13, 2026

Deanna D. Strable-Soethout - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Amy W. Schulman - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Ryan M. Schneider - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Ramiro G. Peru - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Antonio F. Neri - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Bahija Jallal - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Lewis Hay III - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Robert L. Dixon Jr. - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Susan D. Devore - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

May 13, 2026

Steven H. Collis - Director

Grant or award

Common Stock

563^{footnote F1,F2}

$0.00

Footnote F1 (shares): Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
Footnote F2 (shares): The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting… Full note on SEC EDGAR

Mar 12, 2026

Amy W. Schulman - Director

Open-market sale

Common Stock

$287.50

$7K

Mar 6, 2026

Charles Morgan Kendrick Jr. - Officer

Open-market sale

Common Stock

3,196

$284.92^{footnote F1}

$911K

Footnote F1 (price): This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer… Full note on SEC EDGAR

Mar 5, 2026

Steven H. Collis - Director

Open-market purchase

Common Stock

3,000

$289.84

$870K

Mar 2, 2026

Ronald W. Penczek - Officer

Grant or award

Common Stock

426^{footnote F3}

$0.00

Mar 2, 2026

Ronald W. Penczek - Officer

Grant or award

Common Stock

1,701^{footnote F4}

$0.00

Mar 2, 2026

Ronald W. Penczek - Officer

Grant or award

Common Stock

266^{footnote F5}

$0.00

Mar 3, 2026

Ronald W. Penczek - Officer

Tax withholding / forfeiture

Common Stock

37^{footnote F1}

$284.03

$11K

Mar 2, 2026

Ronald W. Penczek - Officer

Grant or award

Employee Stock Option (Right to Buy)

1,677

$0.00

Mar 2, 2026

Ronald W. Penczek - Officer

Tax withholding / forfeiture

Common Stock

131^{footnote F1}

$294.07

$39K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
Footnote F4 (shares): Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028.
Footnote F5 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Mar 2, 2026

Erin M. Wessling - Officer

Grant or award

Common Stock

2,976^{footnote F1}

$0.00

Mar 3, 2026

Erin M. Wessling - Officer

Tax withholding / forfeiture

Common Stock

417^{footnote F2}

$284.03

$118K

Mar 2, 2026

Erin M. Wessling - Officer

Grant or award

Employee Stock Option (Right to Buy)

11,754

$0.00

Footnote F1 (shares): Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
Footnote F2 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Mar 3, 2026

Ryan R. Craig - Officer

Tax withholding / forfeiture

Common Stock

309^{footnote F1}

$284.03

$88K

Mar 2, 2026

Ryan R. Craig - Officer

Grant or award

Employee Stock Option (Right to Buy)

11,754

$0.00

Mar 2, 2026

Ryan R. Craig - Officer

Tax withholding / forfeiture

Common Stock

25^{footnote F1}

$294.07

$7K

Mar 2, 2026

Ryan R. Craig - Officer

Grant or award

Common Stock

2,976^{footnote F2}

$0.00

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.

Mar 2, 2026

Felicia F. Norwood - Officer

Grant or award

Common Stock

5,951^{footnote F2}

$0.00

Mar 2, 2026

Felicia F. Norwood - Officer

Grant or award

Common Stock

2,865^{footnote F3}

$0.00

Mar 3, 2026

Felicia F. Norwood - Officer

Tax withholding / forfeiture

Common Stock

496^{footnote F1}

$284.03

$141K

Mar 2, 2026

Felicia F. Norwood - Officer

Grant or award

Employee Stock Option (Right to Buy)

23,512

$0.00

Mar 2, 2026

Felicia F. Norwood - Officer

Tax withholding / forfeiture

Common Stock

1,421^{footnote F1}

$294.07

$418K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,983 shares on 3/2/2027, and 1,984 shares each on 3/2/2028 and 3/2/2029.
Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Mar 2, 2026

Ratnakar Lavu - Officer

Grant or award

Employee Stock Option (Right to Buy)

20,152

$0.00

Mar 2, 2026

Ratnakar Lavu - Officer

Tax withholding / forfeiture

Common Stock

315^{footnote F1}

$294.07

$93K

Mar 2, 2026

Ratnakar Lavu - Officer

Grant or award

Common Stock

5,101^{footnote F2}

$0.00

Mar 2, 2026

Ratnakar Lavu - Officer

Grant or award

Common Stock

6,802^{footnote F3}

$0.00

Mar 3, 2026

Ratnakar Lavu - Officer

Tax withholding / forfeiture

Common Stock

222^{footnote F1}

$284.03

$63K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,700 shares each on 3/2/2027 and 3/2/2028, and 1,701 on 3/2/2029.
Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 3,401 shares each on 3/2/2027 and 3/2/2028.

Mar 3, 2026

Charles Morgan Kendrick Jr. - Officer

Tax withholding / forfeiture

Common Stock

467^{footnote F1}

$284.03

$133K

Mar 2, 2026

Charles Morgan Kendrick Jr. - Officer

Grant or award

Employee Stock Option (Right to Buy)

15,870

$0.00

Mar 2, 2026

Charles Morgan Kendrick Jr. - Officer

Tax withholding / forfeiture

Common Stock

1,211^{footnote F1}

$294.07

$356K

Mar 2, 2026

Charles Morgan Kendrick Jr. - Officer

Grant or award

Common Stock

4,017^{footnote F2}

$0.00

Mar 2, 2026

Charles Morgan Kendrick Jr. - Officer

Grant or award

Common Stock

2,532^{footnote F3}

$0.00

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 1,339 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Mar 2, 2026

Peter D. Haytaian - Officer

Tax withholding / forfeiture

Common Stock

1,201^{footnote F1}

$294.07

$353K

Mar 2, 2026

Peter D. Haytaian - Officer

Grant or award

Common Stock

2,865^{footnote F2}

$0.00

Mar 3, 2026

Peter D. Haytaian - Officer

Tax withholding / forfeiture

Common Stock

446^{footnote F1}

$284.03

$127K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Mar 2, 2026

Mark Kaye - Officer

Grant or award

Employee Stock Option (Right to Buy)

25,188

$0.00

Mar 2, 2026

Mark Kaye - Officer

Tax withholding / forfeiture

Common Stock

271^{footnote F1}

$294.07

$80K

Mar 2, 2026

Mark Kaye - Officer

Grant or award

Common Stock

6,377^{footnote F2}

$0.00

Mar 2, 2026

Mark Kaye - Officer

Grant or award

Common Stock

10,202^{footnote F3}

$0.00

Mar 3, 2026

Mark Kaye - Officer

Tax withholding / forfeiture

Common Stock

353^{footnote F1}

$284.03

$100K

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029.
Footnote F3 (shares): Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.

Mar 2, 2026

Gail Boudreaux - Officer

Grant or award

Common Stock

10,527^{footnote F3}

$0.00

Mar 3, 2026

Gail Boudreaux - Officer

Tax withholding / forfeiture

Common Stock

1,736^{footnote F1}

$284.03

$493K

Mar 2, 2026

Gail Boudreaux - Officer

Grant or award

Employee Stock Option (Right to Buy)

63,818

$0.00

Mar 2, 2026

Gail Boudreaux - Officer

Tax withholding / forfeiture

Common Stock

6,713^{footnote F1}

$294.07

$1.97M

Mar 2, 2026

Gail Boudreaux - Officer

Grant or award

Common Stock

16,153^{footnote F2}

$0.00

Footnote F1 (shares): PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2 (shares): Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.
Footnote F3 (shares): Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.

Filed

Filer

Relationship

Market value

Notice

Jul 7, 2026

View on EDGAR

Jun 12, 2026